Fundz

Infinitopes Precision Immunomics secures £12.8m seed financing led by Octopus Ventures to enhance Precision Immunomics™ antigen discovery technologies and start phase I/IIa study for lead vaccine, ITOP1

PRIVATEApr 30, 2024

Amount Raised

£12.8 Million

Round Type

Seed

OxfordshireBiotechnologyHealth CareArtificial Intelligence

Investors

Expert Angel InvestorsWilbe CapitalSaras CapitalMeltwind AdvisoryMartlet CapitalManta RayKindred CapitalCris Cancer FoundationCancer Research InstituteCancer Research HorizonsOctopus Ventures

Description

Infinitopes Precision Immunomics has completed a £12.8m seed funding round led by Octopus Ventures. The funding will support enhancements to its Precision Immunomics™ antigen discovery technologies and the start of a phase I/IIa study for its lead vaccine, ITOP1.

Quick answer

Infinitopes raised £12.8 Million in a Seed round, dated April 30, 2024. Investors: Expert Angel Investors, Wilbe Capital, Saras Capital, Meltwind Advisory, Martlet Capital, Manta Ray, Kindred Capital and Cris Cancer Foundation. Infinitopes is based in Oxfordshire, England, United Kingdom.

How much did Infinitopes raise?
Infinitopes raised £12.8 Million in a Seed round on April 30, 2024.
Who invested in Infinitopes?
Expert Angel Investors, Wilbe Capital, Saras Capital, Meltwind Advisory, Martlet Capital, Manta Ray, Kindred Capital and Cris Cancer Foundation are named as investors in this round.
What does Infinitopes do?
Infinitopes is a pioneer in precision immunomics medicines.
Where is Infinitopes based and how big is it?
Infinitopes is based in Oxfordshire, England, United Kingdom. Fundz records about 26 employees.
Who are the decision-makers at Infinitopes?
Fundz holds 1 contact at Infinitopes. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology and Health Care around the same time

Companies in the same sectors as Infinitopes that raised within 45 days of this round, from Fundz verified event records.

  • Omniscient Neurotechnology raised $60M (Series C) on June 11, 2024.
  • i'SUPPLY raised $2.5M (Pre-Series A) on June 11, 2024.
  • Eko Health raised $41M (Series D) on June 5, 2024.
  • Formation Bio raised $372M on May 21, 2024.
  • SmarterDx raised $50M (Series B) on May 14, 2024.
  • Grove AI raised $4.9M (Seed) on May 14, 2024.

Who to call at Infinitopes, and when

A new round usually means Infinitopes is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Infinitopes raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Infinitopes, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Infinitopes. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Infinitopes

Location

Oxfordshire, England, United Kingdom

About

Infinitopes is a pioneer in precision immunomics medicines. A Cancer Research UK (CRUK)-led biotech spinout from Oxford University, we are empowering the immune system to fight cancer metastases with unique, de novo antigen discovery technologies, innovative high efficiency vectors and intelligent clinical trial design. Our mission is to significantly enhance patient survival.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Infinitopes raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Infinitopes's next move

See what Strategic adds

Infinitopes raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.